CDXS — CODEXIS, INC.

—
Nasdaq · Materials · Chemicals · CIK 1200375 ·
Last close
$1.07
Market Cap
$117.27M
52W High
$2.98
52W Low
$0.90
ADV30
945,112
Next earnings
2026-11-12
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 19,262,000 15,248,000 -7,436,000 -8,128,000 144,221,000 29,213,000 92,983,000
Jun 2026 14,915,000 11,403,000 -11,229,000 -12,005,000 120,055,000 27,172,000 87,097,000
Mar 2026 15,248,000 13,184,000 -8,043,000 -8,704,000 129,370,000 36,571,000 86,136,000
Dec 2025 38,915,000 36,872,000 13,966,000 9,601,000 147,797,000 50,793,000 97,268,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-10,404,000
Investing CF
$11,164,000
Financing CF
$121,000
CapEx
$-1,776,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.34
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-627,489,000
Inventory
$1,602,000
Receivables
$11,647,000
ST Investments
$27,746,000
EBIT TTM
$-25,172,000
Pretax Income TTM
$-30,651,000
Interest Exp TTM
$5,479,000
Analysts
7

Yahoo Snapshot (yfinance, live)

Total Revenue
$88,341,000
EBITDA
$-7,753,000
Free Cash Flow
$244,125
Enterprise Value
$126,741,136
Total Cash
$72,659,000
Total Debt
$72,267,000
Shares Out
109,597,529
Trailing EPS
$-0.18
Book Value
$0.47
ROE
-42.9%
ROA
-5.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 70,387,000 -38,332,000 -43,974,000 147,797,000 97,268,000 50,529,000 -19,376,000
Dec 2024 59,345,000 -58,354,000 -65,276,000 149,011,000 82,084,000 66,927,000 -49,410,000
Dec 2023 70,143,000 -54,801,000 -76,240,000 136,561,000 49,946,000 86,615,000 -52,638,000
Dec 2022 138,590,000 -31,714,000 -33,592,000 250,393,000 105,596,000 144,797,000 11,284,000

TTM Snapshot

Revenues TTM
$77,679,000
NetIncome TTM
$-30,723,000
OpCashFlow TTM
—
Assets (Latest)
$120,055,000
Forward EPS
$-0.32

Peers — same industry

TickerNameMarket CapLastDaily %
SLSN SOLESENCE, INC. $119.39M $1.69 —
ACNT ASCENT INDUSTRIES CO. $113.76M $12.61 —
CBUS Cibus, Inc. $106.53M $1.39 —
YSG Yatsen Holding Ltd $132.65M $2.08 —
LODE Comstock Inc. $102.68M $1.35 —

News headlines (Yahoo Finance, 1h cache)

Codexis, Inc. Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
Codexis (CDXS) Q3 2026 Earnings Call Transcript
2026-11-13 06:48 · Yahoo
Codexis Inc (CDXS) (Q3 2026) Earnings Call Highlights: Revenue Surges 124% as ECO Synthesis ...
2026-11-13 05:04 · Yahoo
What Codexis (CDXS) Said on Its Q3 Earnings Call
2026-11-13 01:14 · Yahoo
Codexis (CDXS) Reports Q3 Loss, Beats Revenue Estimates
2026-11-12 22:05 · Yahoo
Codexis: Q3 Earnings Snapshot
2026-11-12 21:32 · Yahoo
Codexis Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-12 21:05 · Yahoo
Codexis Enters into $60 Million Term Loan Facility with Trinity Capital
2026-11-10 11:00 · Yahoo
Codexis Advances ECO Synthesis Toward Adoption Readiness with Quality at Scale and Expanded siRNA Manufacturing Capabilities
2026-11-09 11:00 · Yahoo
Codexis to Report Third Quarter 2026 Financial Results on November 12
2026-10-29 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.